To assess the effect of dopamine on the function of Th17-cells, samples of CD4+ T-cells were cultured in the presence of dopamine (Sigma, USA) at a concentration of 10–5 M [9 (link)] for 15 min. whereafter anti-CD3/CD28-microbeads were added to the cultures.
To study the involvement of dopaminergic receptors in dopamine-mediated modulation of cytokine production, some samples of CD4+ T-cells were pre-incubated with antagonists of D1- or D2-like dopaminergic receptors (SCH23390 and sulpiride respectively) (both from Sigma, USA) at a concentration of 10–5 M [9 (link)] for 15 min, whereafter dopamine (at 10–5 M) was added to the cultures and stimulation was proceeded.
To study the direct effect of blockading or activation of the dopaminergic receptor, CD4+ T-cells were pre-incubated in the presence of D1- or D2-like receptors antagonists (SCH23390 and sulpiride respectively [at 10–5 M]) or D2-like receptor agonist (quinpirole [at 10–7 M] Tocris, Switzerland) and activated by anti-CD3/CD28-microbeads [18 (link)].